Depression News and Research

Latest Depression News and Research

Neurologix announces positive results from Phase 2 trial of NLX-P101 for advanced PD

Neurologix, Inc., today announced positive results in a Phase 2 trial of its investigational gene therapy for advanced Parkinson's disease, NLX-P101. Study participants who received NLX-P101 experienced statistically significant and clinically meaningful improvements in off-medication motor scores compared to control subjects who received sham surgery.

22 Jun 2010

Veterans with substance use disorders utilize violent means to commit suicide: Study

Veterans with substance use disorders who die by suicide are more likely to use violent means (such as a firearm) rather than nonviolent means (such as a drug overdose), new research suggests.

22 Jun 2010

Omega-3 effective for treating depression in patients without anxiety disorders

The use of Omega-3 supplements is effective among patients with major depression who do not have anxiety disorders, according to a study directed by Dr. Fran-ois Lesp-rance of the Centre de recherche du Centre hospitalier at the Universit- de Montr-al (CRCHUM), head of CHUM's Department of Psychiatry and a professor at the Universit- de Montr-al. The study was published June 15 in the online Journal of Clinical Psychiatry.

22 Jun 2010

PPC Canada announces alliance with LifeSpeak

PPC Canada is pleased to announce an alliance with LifeSpeak Inc., designed to help customer employees across Canada work, learn and thrive. The addition of LifeSpeak's online, expert-led video clips to PPC Canada's current suite of offerings will provide employees with a just-in-time learning tool integrated into their Employee Assistance Program.

22 Jun 2010

"Lap Band" weight loss surgery improves physical, psychological health in extremely obese adults

One year after weight loss surgery with laparoscopic gastric banding, extremely obese adults demonstrate not only better physical health but also improved psychological health, a new study shows. The results will be presented Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.

21 Jun 2010

Beyond Moose and Mountains initiative focuses on building Canada's business and regulatory environment

At its 2010 annual general meeting in Montreal yesterday, the national biotechnology association, BIOTECanada, confirmed a national team of industry leaders, whose expertise will ensure Canada keeps growing what today is an $84 billion bio-economy.

21 Jun 2010

Achieving remission in patients lessens burden of RA on societies with aging populations: Study

Achieving disease remission in patients with rheumatoid arthritis provides superior outcomes across measures of socio-economic importance including work productivity and quality of life according to results presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. These Austrian findings are reported in addition to improvements in measures of physical functioning, when compared with RA patients achieving low disease activity.

21 Jun 2010

Lightning Safety Awareness Campaign reduces death and injury from lightning strikes in the U.S.

This year marks the 10th Lightning Safety Awareness Campaign, June 20-26. Spearheaded by the National Weather Service, the campaign has reduced death and injury from lightning strikes in the U.S., with average annual deaths dropping from 72 to 40 in the last decade.

19 Jun 2010

esperanza Magazine's feature article Marriage Matters wins 2010 MHA Media Award

esperanza Magazine's feature article "Marriage Matters" has won a Mental Health America 2010 Media Award in the national magazine category. esperanza Magazine was among 15 media outlets honored by MHA at an awards luncheon held June 12 during the advocacy organization's 2010 annual conference in Washington, DC. The awards honor excellence in reporting and portrayals of mental health issues.

19 Jun 2010

Yoga and meditation in Western medicine

Meditation and deep breathing techniques, as a form of relaxation, have been in use for thousands of years. However, in the unique new book Pranayama (published by AuthorHouse), author Dr. Ravinder Jerath presents explanations and illustrations to more easily and succinctly explain exactly how meditation and deep breathing techniques beneficially affect the human body.

18 Jun 2010

Serotonin transporter gene appears to increase one's risk for depression, PTSD: Study

There is a great deal of interest in factors that contribute to the vulnerability to developing post-traumatic stress disorder, or PTSD. One factor that appears to contribute to the heritable vulnerability to PTSD is a variation in the gene that codes for the serotonin transporter, also known as the serotonin uptake site. Having a shorter version of the serotonin transporter gene appears to increase one's risk for depression and PTSD after exposure to extremely stressful situations.

18 Jun 2010

Research examines relationship between body-image distortion and weight-loss behaviors

Normal weight and underweight teenage girls who falsely believe they are overweight are at significantly greater risk of succumbing to unnecessary and unsafe weight-loss behaviors than girls who can accurately assess their weight status, according to new research by a University of Illinois expert in eating disorders and body-image perception.

18 Jun 2010

Study finds anxiety/panic disorder as most-disabling psychiatric disorder associated with TS

An assessment of patients with adult Tourette syndrome (TS) to identify clinical factors that contribute to psychosocial and occupational disabilities resulting from the vocal or motor tics that define TS found that anxiety/panic disorder may be the most disabling psychiatric condition associated with the disorder.

18 Jun 2010

Possible mechanism identified for how lithium treats bipolar disorder

Lithium has been established for more than 50 years as one of the most effective treatments for manic depression, clinically termed bipolar disorder. However, scientists have never been entirely sure exactly why it is beneficial.

18 Jun 2010

Alkermes receives tentative schedule notification for FDA advisory committee meeting on VIVITROL sNDA

Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.

18 Jun 2010

Study reveals increase of enzyme MAO-A in female brain during immediate postpartum period

Within the first week after giving birth, up to 70 percent of all women experience symptoms of the baby blues. While most women recover quickly, up to 13 percent of all new mothers suffer from symptoms of a clinical-level postpartum depression. Postpartum depression is defined as a major depressive episode starting within 4 weeks after delivery and is a significant public health problem. Postpartum blues represents a major risk factor for developing postpartum depression and severe postpartum blues symptoms can be viewed as a prodromal stage for postpartum depression.

17 Jun 2010

Positive results from Phase I clinical trial of GLYX-13 presented at NCDEU meeting

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that it presented data at the NCDEU 50th Anniversary Meeting showing that its novel mechanism compound GLYX-13 appeared safe in a Phase I trial. GLYX-13 is a glycine site functional partial agonist selective modulator of the NMDA receptor that is being developed initially for use in depression as adjunctive therapy.

17 Jun 2010

Neurocrine Biosciences, Boehringer Ingelheim collaborate to develop GPR119 agonists for Type II diabetes

Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.

17 Jun 2010

New book gives hope to women and families who are in difficult stages of anorexia treatment

Women and families struggling with an eating disorder or another addiction should never lose sight of the need to sustain the spirit, according to a new book by Jena Morrow, an author in recovery after more than 20 years with anorexia nervosa. Morrow, a behavioral health specialist at Timberline Knolls Residential Treatment Center, details a battle with anorexia that begins in early childhood in Hollow: An Unpolished Tale, recently released by Moody Publishers.

17 Jun 2010

Research findings shed light on risk factors, prevention strategies for suicide

Masculine ideals of strength coupled with strong family ties can help men combat depression and overcome thoughts of suicide, according to University of British Columbia research.

17 Jun 2010

Depression News and Research

Latest Depression News and Research

Neurologix announces positive results from Phase 2 trial of NLX-P101 for advanced PD

Veterans with substance use disorders utilize violent means to commit suicide: Study

Omega-3 effective for treating depression in patients without anxiety disorders

PPC Canada announces alliance with LifeSpeak

"Lap Band" weight loss surgery improves physical, psychological health in extremely obese adults

Beyond Moose and Mountains initiative focuses on building Canada's business and regulatory environment

Achieving remission in patients lessens burden of RA on societies with aging populations: Study

Lightning Safety Awareness Campaign reduces death and injury from lightning strikes in the U.S.

esperanza Magazine's feature article Marriage Matters wins 2010 MHA Media Award

Yoga and meditation in Western medicine

Serotonin transporter gene appears to increase one's risk for depression, PTSD: Study

Research examines relationship between body-image distortion and weight-loss behaviors

Study finds anxiety/panic disorder as most-disabling psychiatric disorder associated with TS

Possible mechanism identified for how lithium treats bipolar disorder

Alkermes receives tentative schedule notification for FDA advisory committee meeting on VIVITROL sNDA

Study reveals increase of enzyme MAO-A in female brain during immediate postpartum period

Positive results from Phase I clinical trial of GLYX-13 presented at NCDEU meeting

Neurocrine Biosciences, Boehringer Ingelheim collaborate to develop GPR119 agonists for Type II diabetes

New book gives hope to women and families who are in difficult stages of anorexia treatment

Research findings shed light on risk factors, prevention strategies for suicide

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Depression News and Research

Latest Depression News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in